Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Dec 9 2016

Full Issue

Former Pharma Executives Bribed Doctors To Prescribe Powerful Opioid, Prosecutors Allege

The former executives of Insys Therapeutics were arrested on Thursday on federal charges.

Stat: Former Insys Execs Charged In Nationwide Conspiracy

The former chief executive of Insys Therapeutics and several other former executives were arrested Thursday on federal charges of conspiring to bribe doctors to prescribe a prescription version of the potent opioid fentanyl. The painkiller, called Subsys, is approved by the Food and Drug Administration for cancer patients who suffer from intense bouts of pain that are not controlled by other opioid medications. In exchange for bribes and kickbacks offered by Insys employees, several doctors wrote large numbers of Subsys prescriptions for patients who did not have cancer, prosecutors said. (Armstrong, 12/8)

The Wall Street Journal: Former Insys CEO Arrested In Opioid Prescription Kickback Case

Six former executives and managers at Insys Therapeutics Inc. were arrested on Thursday and charged with conspiring to defraud health insurers and bribe doctors in exchange for prescribing the company’s fentanyl painkiller, Subsys, the Justice Department said. Among those arrested were former Chief Executive Michael Babich, who resigned from the company in November 2015. Mr. Babich, 40 years old, was charged with conspiracy to commit racketeering, conspiracy to commit wire and mail fraud, and conspiracy to violate the anti-kickback law. (Walker, 12/8)

Stat: Company Gave Doctor ‘One Of The Best Nights Of His Life’ To Boost Fentanyl Sales

Two top sales officials of Insys Therapeutics entertained the physician at a “club,” where they stayed until 4 a.m. “Went fantastic last night,” one of the company’s regional sales managers wrote in a text message to a sales rep, the indictment says. “He had to have had one of the best nights of his life.” The next week, the doctor wrote 17 prescriptions for Subsys — a legal form of the opioid fentanyl — when he usually averaged about three. He also received $260,050 in payments over three years for participating in the Insys speaking program — something federal officials allege was nothing more than a mechanism for bribing doctors. (Armstrong, 12/8)

In other news on the opioid crisis —

The Philadelphia Inquirer: Jury Convicts Philly Doctor Who Ran Pill Mills

A federal jury on Thursday convicted a doctor with running a pill mill out of his offices in Roxborough and Bryn Mawr on 308 counts, including 269 of drug distribution, and one count of drug distribution resulting in death. (12/8)

Denver Post: New Methadone Program For Denver Probationers Resulting In Tears Of Relief For Participants 

Tears of relief recently ran down one participant’s face as he entered a new program aimed at getting troubled drug offenders treatment. The new initiative is less than two months old, but already it is paying dividends, according to those running it. Of the seven people who started the Medication Assisted Treatment Induction Program for Denver probationers, four remain enrolled. The program aims to identify troubled probationers who aren’t complying with requirements that they remain drug free. It gives them the option of receiving methadone treatment while in jail. Then they  are handed off to an outpatient treatment program upon their release from custody. (Osher, 12/8)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, July 14
  • Monday, July 13
  • Friday, July 10
  • Thursday, July 9
  • Wednesday, July 8
  • Tuesday, July 7
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF